TOP STORIES

• REGULATORY MHLW Device Review Chief Pledges Evidence-Based Approvals amid Diversifying Technologies
  August 6, 2025

• REGULATORY MHLW Trial Office Head Vows to Make Japan a Preferred Site for Clinical Studies
  August 5, 2025

• REGULATORY Wage-Based Price Premiums on Drugs Not an Option, Says MHLW Insurance Chief
  August 4, 2025

• BUSINESS Nihon Chouzai to Go Private through Tender Offer Backed by Advantage Partners
  August 1, 2025

• ORGANIZATION Japan Society Poised to Set Out Criteria to Standardize Regional Formularies, Eyes August Release
  July 31, 2025

• REGULATORY MHLW to Link GS1 and YJ Codes in Public Database, Launch Planned for FY2028
  July 30, 2025

• BUSINESS Gene Therapy Deaths Spur Strategic Rethink among Biotechs, Merck Exec Notes Investor Caution
  July 30, 2025

• REGULATORY Post-Marketing Oversight and Regulatory Reviews Must Work as One, Says New MHLW Safety Chief
  July 29, 2025

• REGULATORY Astellas Employee Did Not Appeal, Prison Sentence Finalized in China
  July 29, 2025

• COMMENTARY Pharmaceutical Policy at a Crossroad amid Political Upheaval in Japan
  July 28, 2025

• REGULATORY MSD’s 21-Valent Pneumococcal Shot Nears Japan Approval; Male Use of Silgard 9 Cleared
  July 25, 2025

• BUSINESS Chugai to Defer Domestic Supply of Elevidys amid Safety Review
  July 25, 2025

• REGULATORY Santen’s Glaucoma Drug, Taisho’s Insomnia Med Up for Panel Review on July 31
  July 25, 2025

• REGULATORY MHLW Plans to Ease Clinical Trial Ad Rules, Eyes Notification by March-End
  July 24, 2025

• BUSINESS Towa Launches Task Force to Tackle Nitrosamine Impurities, Share Solutions with Peers
  July 24, 2025

• REGULATORY New MHLW Drug Review Chief Aims to Dispel “Barrier” Perception, Pledges Active Engagement with Industry
  July 23, 2025

• REGULATORY Healthcare Stakeholders Weigh Fallout after Ruling Bloc’s Election Setback
  July 23, 2025

• REGULATORY Japan’s Ruling Bloc Routed in Upper House Poll; Takemi to Retire, Furukawa, Kamayachi, and Honda Secure Seats
  July 22, 2025

• BUSINESS JRI Urges Reforms in Pricing and Reimbursement to Support Regenerative Medicine Ecosystem
  July 18, 2025

• REGULATORY Japan Begins FY2026 CEA Reform Talks, Re-Designation after Market Expansion Up for Debate
  July 17, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• …
• Next ›
• 最終 »